Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
マーケット
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Tape desk, TradeNews BD (2026-10-13): Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim. 一次ソース: CNBC Top News の原文 (cnbc.com).